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Hepatitis delta virus (HDV) is composed of four specific components. The first component is envelope
protein which contains hepatitis B surface antigens. The second and third components are nucleocapsid
proteins, referred to as small and large hepatitis delta antigens (HDAgs). The final component is a
single-stranded circular RNA molecule known as the viral genome. In order to study the mechanism of HDV
RNA packaging, a four-plasmid cotransfection system in which each viral component was provided by a
separate plasmid was employed. Virus-like particles released from Huh-7 cells receiving such a cotransfection
were found to contain HDV RNA along with three proteins. Therefore, the four-plasmid cotransfection system
could lead to successful HDV RNA packaging in vitro. The system was then used to show that the large HDAg
alone was able to achieve a low level of HDV RNA packaging. Analysis of a variety of large HDAg mutants
revealed that the RNA-binding domain was essential for viral RNA packaging. By increasing the incorporation
of small HDAg into virus-like particles, we found a three- to fourfold enhancement of HDV RNA packaging.
This elect was probably through a direct binding ofHDV RNA, independent from that oflarge HDAg, with the
small HDAg. The subsequent RNA-protein complex was packaged into particles. The results provided insight
into the roles and functional domains of small and large HDAgs in HDV RNA packaging.
The virion of hepatitis D virus (HDV) is a 36-nm particle
consisting of four specific components (1, 15). The envelope is
composed of hepatitis B surface antigens (HBsAgs) provided
by the helper hepatitis B virus (HBV) (1, 16). Inside the virion
are two HDV-specific antigens, namely, the large and small
hepatitis delta antigens (HDAgs) (1, 15). Also inside the virion
is the 1.7-kb single-stranded circular RNA genome (15, 23).
The assembly of these components into a mature virion is
addressed in this study.
The in vitro production of HDV in tissue culture has been
accomplished by the cotransfection of HDV cDNA and HBV
DNAin Huh-7 cell lines (16, 24). It is therefore a useful system
to study the components participating in HDV assembly. The
HBsAgs are shown to be essential for HDV virion formation,
(16, 19), with the smallest form of HBsAg being sufficient to
accomplish virion assembly (22). However, the large form of
HBsAg is required for infectivity ofHDVvirions (18). Regard-
ing the function of these two HDV-specific antigens, the large
HDAg is essential for HDV assembly (3) and can be packaged
into HBsAg particles by itself (6, 16). In contrast, the small
HDAg alone could not be packaged into HBsAg particles but
depends on a protein-protein interaction with the large HDAg
(6, 11). The primary role of each viral protein in HDV virion
assembly is known, although details of their function merit
further investigation. However, packaging of the central com-
ponent of HDV, the viral genome (HDV RNA), is poorly
understood.
Factors involved in packaging of the HDV genome probably
can be divided into two groups. One is the trans-acting
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components, such as viral small and large HDAgs or cellular
factors. The other is the cis-acting elements, such as RNA
conformation or the nucleic acid packaging signals. In order to
study these components, we first had to establish an in vitro
HDV RNA packaging system. From previous work, we and
others showed that by cotransfection of three plasmids (each
expressing HBsAgs and large or small HDAg, respectively)
into Huh-7 cells, the three proteins could assemble into
virus-like particleswhich contain no viral RNA (6, 16). Branch-
ing out from this system, we considered whether further
cotransfection with an additional plasmid expressing the full-
length HDV RNA could lead to packaging of viral RNA into
particles. If such a experiment worked, it could be used to
study the role ofeach specific component ofthe HDV virion in
RNA packaging.
Plasmids supplying the HBsAg and large and small HDAgs
are already available (3, 10, 22). However, a plasmid which
provides HDV RNA has not been perfected. Because wild-
type HDV RNA itself can replicate after transfection into cells
and subsequently generate both the large and small HDAgs (5,
8), it is not possible to address separately the roles of each
individual HDAg in viral RNA packaging. To solve these
problems, we followed a previous strategy and used a mutant
HDV in which the HDAg open reading frame (ORF) was
disrupted by a two-base deletion, thus destroying its self-
replication capacity (10, 21). The mutant HDV cDNA was
placed under the control ofthe potent cytomegalovirus (CMV)
early promoter in order to maximize the level of RNA
expression (2).
In this report, we present evidence that such a cotransfection
system is successful in HDV RNA packaging in vitro. It was
then used to dissect the role and protein functional domain of
HDAgs involved in RNA packaging. The results advanced our
understanding of the mechanism of HDV RNA packaging.
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MATERUILS AND METHODS
Plasmids. pSVLD3 contains a tandem trimer of the full-
length, wild-type HDV cDNA under the control of the simian
virus 40 late promoter. It was used in transfection experiments
to initiate viral genome replication and both large and small
HDAg production (10). pSVDAg-L contains a BamHI-PstI
subgenomic fragment of HDV cDNA under the control of the
simian virus 40 promoter and expresses the large HDAg (3).
pSVDAg-S is a plasmid containing a subgenomic HDV cDNA
fragment and expresses the small HDAg only (10). Finally,
pS1X contains an HBV subgenomic fragment (ApaI-BglII) and
was used to express three forms of HBsAg (22).
Construction of a plasmid expressing mutant HDV RNA.
The construct was prepared as shown in Fig. 1A. In brief, an
HDV cDNA monomer (pXX-; 20) was cleaved at the unique
SacII site in the HDAg ORF (Fig. 1A) and then made blunt
ended by treatment with Klenow fragment. After self-ligation
and transformation into Escherichia coli, a plasmid with a
deletion of two nucleotides at amino acid 10 of the HDAg
coding region was obtained. The mutation was confirmed by
sequencing analysis. A tandem dimer of such a mutant was
cloned under the control of the human CMV immediate-early
promoter in two orientations. One plasmid which expressed
genomic HDV RNA (pCDm2G) was used in this study (Fig.
1A).
Construction of plasmids expressing mutant HDAgs defec-
tive in the oligomerization, RNA-binding, or carboxyl-terminal
domain. Plasmids expressing mutant HDAgs with defective
oligomerization capacity were kindly provided by Michael Lai
(12, 25). Because of the substitution of two leucine residues in
the coiled-coil structure (Fig. 1B, CCS) by glycine and valine
(pSGVL) or by glycine and glycine (pSGGL), the oligomeriza-
tion capacity of small HDAg is reduced about 50% in the
former and almost completely in the latter (25). Two more
plasmids, pLGVL and pLGGL, expressing mutant large
HDAg with the above-mentioned defects, were also obtained
(Fig. 1B) (25). A plasmid expressing mutant small HDAg
defective in RNA binding was obtained from a previous study
(12) in which two critical arginine residues in the first arginine-
rich motif (ARM) of the RNA-binding domain of small HDAg
were changed to glycine and glutamine (plasmid pdAl). The
mutant small HDAg could not bind HDV RNA and could not
support HDV RNA replication (12). In order to prepare a
plasmid expressing mutant large HDAg with a similar defect,
the SacII-SmaI fragment (covering the RNA-binding domain)
of this mutant plasmid was used to replace the corresponding
part in the wild-type large HDAg to make plasmid pDA1 (Fig.
1B).
To construct a plasmid expressing mutant small HDAg
truncated in the carboxyl terminus, pSVDAg-S (expressing
wild-type small HDAg) was cleaved with SmaI at a position
corresponding to amino acid 163 and then cleaved with BamHI
in the vector backbone. Afterwards the ends were repaired by
filling in with Klenow fragment, and then they were self-
ligated. The final plasmid, pddC, expressed a fusion protein
containing the first 163 amino acids of small HDAg and 19
irrelevant amino acids derived from the vector sequences.
DNA transfection ofHuh-7 cell lines. Transfection of Huh-7
cells was performed by the calcium phosphate precipitation
method (14, 24). In general, 4 x 106 cells were seeded onto a
100-mm-diameter petri dish and were inoculatedwith a total of
40 jig of DNA. The amount of each plasmid used was 10 ,ug
(unless specified in experiments), and salmon sperm DNA was
used to keep the total amount of DNA per transfection
constant. Culture medium was collected on days 3, 6, and 9
posttransfection to characterize the particles produced. The
efficiency of transfection was monitored by determining the
amount of HBsAg released into the medium by use of a
commercial enzyme-linked immunoassay (IMX; Abbott).
Quantitative comparisons of RNA packaging among particles
produced in different cotransfection experiments varied by less
than 10% in their transfection efficiency.
Purification and characterization of viral particles. Ten
milliliters of culture medium was collected and then clarified
by spinning at 12,000 rpm in a J2-21 centrifuge (Beckman) for
30 min. The supernatant was layered over a 20% sucrose
cushion and then was spun down in an SW28 rotor at 25,000
rpm for 17 h (model L-8M; Beckman). The pellet was dis-
persed by repeated pipetting and dissolving in 150 to 200 ,ul of
10 mM Tris-1 mM EDTA (TE buffer) (adjusted to transfec-
tion efficiency). For isopycnic centrifugation, the dissolved
pellet was put on top of a preformed discontinuous CsCl
gradient (from 1.19 to 1.51 g/cm3) in an SW41 rotor. After
centrifugation at 35,000 rpm for 24 h (L8-M; Beckman), 0.5-ml
fractions were collected from the bottom until the tube was
empty. The refractive index of each fraction was determined by
a refractometer and then was converted into density. To collect
viral particles, 0.5 ml from each fraction was diluted with 6
volumes of phosphate-buffered saline and then centrifuged in
a TLA100.3 rotor (TL-100; Beckman) at 60,000 rpm for 2 h. A
dissolved pellet from each fraction was used for viral RNA and
viral antigen detection to locate the fraction(s) containing
HDV-like particles.
Northern (RNA) and Western immunoblotting procedures.
Total RNA from transfected Huh-7 cells or from viral pellets
was isolated by the single-step method (7). Northern blotting
to detect HDV RNA and preparation of riboprobe were
performed as previously described (3). Unless specified, the
exposure time for autoradiography was 20 h (overnight). For
protein detection, 30 RI of dissolved pellet was used to examine
the viral antigen in the particles by Western blotting proce-
dures (3, 6). The primary antibody was a high-titer human
polyclonal antiserum against HDAgs, as used in a previous
study (3). A horseradish peroxidase-conjugated sheep anti-
human immunoglobulin antibody was used as the secondary
antibody (Amersham). Reacted protein was detected by a
chemiluminescence method (the ECL system from Amer-
sham). The exposure time was 2 to 5 min. The signals of HDV
RNA and HDAgs were traced by a densitometer for compar-
ison (Bio-Rad model 620 video densitometer).
RESULTS
Production of the monomeric form of mutant HDV RNA in
cells transfected with pCDm2G. In order to investigate the role
of each viral component in the packaging of HDV RNA, we
employed a cotransfection system in which each component of
the HDV virion was supplied by an individual plasmid. Three
plasmids were used previously to provide the HBsAgs and
large and small HDAg, respectively (3, 10, 22). We then con-
structed a plasmid (pCDm2G) that transcribed the genomic
strand of a tandem dimer of mutant HDV cDNA (two bases
deleted in the HDAg gene) (Fig. 1A).
Plasmid pCDm2G was transfected into Huh-7 cells to test
whether a full-length mutant HDV RNA could be produced.
Total cellular RNAwas extracted from Huh-7 cells at 3, 6, and
9 days posttransfection for Northern blot analysis. Signals of
1.7-kb monomeric HDV RNAwere clearly seen (Fig. 2A, lanes
1 to 3). The results suggested that the primary transcript from
pCDm2G (the 3.4-kb species in Fig. 2A, lanes 1 to 3) could
undergo self-processing to generate a full-length, monomeric
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FIG. 1. (A) Diagram showing the construction of plasmids expressing the replication-defective HDV RNA. The thick open box in plasmid
pXX- represents the HDV sequence, the solid arrow represents the ORF of HDAg. A thin arrow on the sequence indicates the cleavage site of
the SacII enzyme. After a series of manipulations (as indicated in the text), two bases were deleted from the HDAg ORF and mutated sequences
are shown to the right. The shaded arrow represents the mutated HDAg ORF. The mutated HDV cDNA was then cloned into the XbaI site of
pCMV-2 in a tandem dimer. Under the control of the CMV early promoter, pCDm2G can transcribe genomic RNA. (B) Diagram showing the
functional domains of small and large HDAgs (S- or L-HDAg, respectively) and important mutation sites. CCS, region of coiled-coil structure at
the amino terminus; ARM, arginine-rich motif important for RNA binding. The isoprenylation site of large HDAg is indicated. The two leucine
residues in the CCS are mutated to glycine and valine in mutant pLGVL but to glycine and glycine in mutant pLGGL. Two arginine residues in
the first ARM of large HDAg are changed to G and Q to make the RNA-binding mutant pDA1. The small HDAg ORF was disrupted by SmaI
digestion (at amino acid 163) to prepare a mutant with a truncated C terminus (pddC).
HDV RNA. The mutant HDV RNA alone, however, could not
self-replicate because its amount declined gradually (Fig. 2A,
lane 1 versus lane 3). To further confirm this, the same blot was
stripped and then rehybridized with a probe detecting anti-
genomic RNA. In Huh-7 cells transfected with plasmid
pCDm2G only, no antigenomic RNA was found (Fig. 2B, lanes
1 to 3). However, in cotransfection experiments with small
HDAg-expressing plasmids, the mutant RNA could initiate
replication (Fig. 2A, lanes 4 to 6) and produce antigenomic
RNA (Fig. 2B, lanes 4 to 6).
A four-plasmid cotransfection system leading to successful
HDV RNA packaging and revealing a significant role of large
HDAg in RNA packaging. After showing that plasmid
pCDm2G could produce monomeric HDV RNA, we then
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FIG. 2. Northern blot analysis of HDV RNA in Huh-7 cells
transfected with plasmid expressing mutant HDV RNA. Huh-7 cells
were transfected with pCDm2G alone (expressing mutant HDV RNA)
(lanes 1 to 3), with pCDm2G plus pSVDAg-S (expressing small
HDAg) (lanes 4 to 6), or with pSVLD3 (expressing wild-type HDV
RNA) (lanes 7 to 9). Total RNA was isolated from these cells at days
3, 6, and 9 posttransfection, and 20 jig was used for Northern blot
analysis, either with a riboprobe detecting the genomic (A) or anti-
genomic (B) strand of HDV RNA. Lanes M, lambda HindIII frag-
ments as markers; lanes C, 10 ,ug of total RNA extracted from Huh-7
cells cotransfected with pSVLD3 plus pSlX (expressing HBsAgs) as a
positive control to show the position of the 1.7-kb HDV genome.
studied whether such a mutant RNA could be packaged. Four
plasmids (expressing HBsAgs, large HDAg, small HDAg, or
mutant HDV RNA) were cotransfected into Huh-7 cells. Four
days after cotransfection, culture media were collected and
virus-like particles were purified for HDV RNA and HDAg
detection. Northern hybridization demonstrated HDV RNA in
the particles (Fig. 3A, lane 3) which also contain both the large
and small HDAgs (Fig. 3A, bottom gel, lane 3). Therefore, the
results indicated that this mutant HDV RNA could be pack-
aged into virus-like particles and suggested this experiment to
be a practical in vitro HDV RNA packaging system.
Next, we investigated the role of individual HDAg in HDV
RNA packaging. The large HDAg has been shown to be
essential for HDV assembly (3) and itself could be packaged
into HBsAg particles (6, 16). It was thus interesting to see
whether the large HDAg alone could help HDV RNA pack-
FIG. 3. Northern and Western blot analyses of HDV RNA and
protein in virus-like particles and cells following cotransfection. (A)
Detection of genomic HDV RNA in virus-like particles from the
culture media of cotransfected Huh-7 cells. Culture media were
collected from Huh-7 cells on day 6 posttransfection with pCDm2G
(lane 2), with pCDm2G + pSjX + pSVDAg-S (1 jig) + pSVDAg-L
(10 jig) (lane 3), with pCDm2G + pSjX + pSVDAg-L (lane 4), with
pCDm2G + pS,X + pSVDAg-S (lane 5), or with pSVLD3 + pS1X
(lane 6). The amount of each plasmid used was 10 ,ug, unless specified.
Virus-like particles were collected by centrifugation, and RNA was
extracted from one-half of the pellet for Northern blot detection of
packaged HDV RNA. Lane 1, 5 jig of total RNA extracted from
Huh-7 cells transfected with pSVLD3 as a size marker for monomeric
HDV RNA. One-third of the same particles was used for immunoblot
detection of HDAgs, and the results are shown at the bottom ofpanel
A. Positions ofthe large (p27) and small (p24) HDAgs are indicated at
the right. (B) Results of Northern blot analysis for genomic HDV
RNA in cotransfected Huh-7 cells. Total cellular RNA was extracted
from cotransfected Huh-7 cells, and 20 jig was used for Northern blot
study. Samples in this panel are organized identically to those ofpanel
A.
aging. To test this possibility, a similar cotransfection experi-
ment was done, excluding the small HDAg-expressing plasmid.
Culture media were collected from transfected Huh-7 cells,
and virus-like particles were purified for the study of HDV
components. As anticipated, large HDAg was packaged into
the particles (Fig. 3A, bottom gel, lane 4). Interestingly, even
without small HDAg, HDV RNAwas still found in the purified
particles (Fig. 3A, lane 4). This result suggested that large
HDAg alone was sufficient in assisting HDV RNA packaging.
As negative controls, in the absence of HBsAg-expressing
plasmid (Fig. 3A, lane 2) or large HDAg-expressing plasmid
(lane 5), no HDV RNA or protein was packaged, although the
level of HDV RNA inside the transfected cells was equal (Fig.
3B, lanes 2 and 5).
Isopycnic centrifugation analysis of virus-like particles for
HDV RNA and HDAgs. In order to further demonstrate that
HDV RNA was actually packaged into virus-like particles
containing HDAgs, we banded the virus-like particles by
isopycnic centrifugation in a cesium chloride gradient. The
fractions were collected and analyzed for both HDV RNA and
HDAgs. For particles containing both large and small HDAgs,
fractions that contained HDAgs (Fig. 4A, lower gel, fractions
12 to 15) were coincidental with those that contained HDV
RNA (Fig. 4A, upper gel, fractions 12 to 15). The peak
fractions (13 and 14) had a density of 1.24 g/cm3. These studies
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FIG. 4. Cesium chloride density gradient analysis of HDV-like particles for viral RNA and protein content. (A) Pellets from culture media of
Huh-7 cells on day 3 posttransfection with pCDm2G (10 ,ug) + pS,X (10 jig) + pSVDAg-L (5 ,ug) + pSVDAg-S (5 jig) were subjected to isopycnic
centrifugation in a discontinuous CsCI gradient. The density profile is at the top. Each fraction was collected and subjected to Northern blot for
detection of HDV (upper gel, autoradiography after exposure for 20 h) and Western blot for detection of large and small HDAgs (p27 and p24,
lower gel). The size of monomeric HDV genome is indicated by an arrowhead. (B) Similar study conducted for isopycnic fractions of virus-like
particles from Huh-7 cells cotransfected with pCDm2G + pS,X + pSVDAg-L (10 jLg each). The autoradiograph ofthe Northern blot was exposed
for 5 days. Positions of HDV RNA and large HDAg (p27) are marked.
confirmed that HDV RNA was indeed packaged into particles
in this cotransfection experiment.
A similar study was conducted on the particles containing
large HDAg only. Pellets recovered from culture media ofHuh-7
cells cotransfected with pCDm2G, pS,X, and pSVDAg-L were
subjected to isopycnic centrifugation. Immunoblotting analysis
found that particles in fractions 14 to 18 contained large HDAg
(Fig. 4B, lower gel). Northern blot analysis could detect HDV
RNA in the same fractions (Fig. 4B, upper gel), with the peak
fraction (no. 15) having a density of 1.24 g/cm3. Such results
indicated that HDV RNA could be packaged into HBsAg
particles containing only large HDAg.
However, the efficiency ofHDV RNA packaging in particles
containing the large HDAg only was less than that in particles
containing both large and small HDAgs. In the peak isopycnic
fractions, the amount of particles containing only large HDAg
appeared to be equivalent to that of particles containing both
large and small HDAgs, as suggested by a similar level of
immunoblotting signals (compare the p27 signal offractions 14
and 15 of Fig. 4B with that of fractions 13 and 14 of Fig. 4A).
Comparison by densitometer quantitation revealed a less than
20% difference. In contrast, the detection of HDV RNA in the
corresponding fractions of the former particles required a
sixfold longer exposure time (5 days) than did those of the
latter particles (20 h). Even after prolonged exposure, their
hybridization signals were still found to be 30 to 50% of those
of the latter. The discrepancy might reflect a functional
difference between large and small HDAg in HDV RNA
packaging.
RNA-binding domain oflarge HDAg essential forHDVRNA
packaging. After identifying a significant role of large HDAg
in assisting viral RNA packaging, we then investigated its
functional domain. On the basis of previous results, large
HDAg probably can be divided into four domains with distinct
functions. The amino-terminal coiled-coil structure (Fig. 1B,
CCS) is an oligomerization domain mediating the protein-
protein interaction (6, 11, 25). The middle region contains two
arginine-rich motifs (Fig. 1B, ARM) and is critical for binding
with HDV RNA. The importance of an RNA-binding domain
in viral replication has been shown (4, 12, 13). The carboxyl-
terminus is a region rich in proline and glycine, with unknown
function. Finally, the C-terminal extreme of 19 amino acids is
posttranslationally modified by isoprenylation and is found to
be essential in virion assembly (9, 11). Large HDAg mutants
which are defective in the C-terminal region performed poorly
in self-packaging (11) and very likely even worse in assisting
RNApackaging. We therefore only focused on the significance
of the coiled-coil structure and the RNA-binding domain in
RNA packaging.
Two coiled-coil domain mutants, pLGVL and pLGGL, were
used. When two leucine residues in the coiled-coil structure
are replaced (by glycine and valine or by glycine and glycine),
the oligomerization activities of pLGVL and pLGGL are
expected to diminish partially or almost completely (25). One
VOL. 68, 1994
A.
6367
C
W,6368 WANG ET AL.
A
0 12 3 4C
B
kb M C 1 2 3 4 5
4.4
_p27 2.3
-p24 2.0- _ . , _ i _ _~~1 .7 kb
C
1 2 3 4 5
* wF*lii :-1.7 kb
FIG. 5. Effect on HDV RNA packaging by large HDAg mutants.
Huh-7 cells were cotransfected with a plasmid expressing HDV RNA
(pCDm2G), a plasmid expressing HBsAg (pS1X), and a plasmid
expressing (i) wild-type large HDAg (pSVDAg-L, lane 3), (ii) mutant
large HDAg profoundly defective in oligomerization (pLGGL, lane 1),
(iii) mutant large HDAg partially defective in oligomerization
(pLGVL, lane 2), or (iv) mutant large HDAg defective in RNA
binding (pDA1, lane 4). Virus-like particles were recovered from the
four kinds of cotransfected cells and used for detection of packaged
HDV RNA (arrow) by Northern blotting (top gel of panel A) and for
detection of HDAgs by immunoblotting (bottom gel of panel A). The
wild-type (lane 3) and three mutant large HDAgs (lanes 1, 2, and 4)
were found at similar levels. In contrast, little HDV RNA was
packaged by mutant large HDAg defective in the RNA-binding
domain (lane 4). Lanes M and C were the same as described in the
legend to Fig. 2. (B) Northern blotting showing the amount of HDV
RNA in the cotransfected Huh-7 cells. The samples were arranged in
a same way as described for panel A.
RNA-binding domain mutant, pDA1, was also used. When two
arginines in the first ARM are replaced, RNA-binding activity
is essentially abolished (12).
The capacity of these three mutants to assist HDV RNA
packaging was tested by cotransfecting each plasmid with two
other plasmids producing HDV RNA (pCDm2G) and express-
ing HBsAg (pS1X) in Huh-7 cells. Virus-like particles were
obtained from culture media by centrifugation. The three
mutant large HDAgs could be packaged into particles, as
shown by immunoblotting studies (Fig. 5A, bottom gel, lanes 1,
2, and 4). After quantitation of the intensity of the protein
signal, all three mutants were found to be packaged with an
efficiency equal to that of wild-type large HDAg (Fig. SA,
bottom gel, lane 3). Such particles were then tested for their
HDV RNA content by Northern blot analysis. HDV RNA was
detected at similar levels in particles containingwild-type large
HDAg (Fig. 5A, lane 3) and containing oligomerization mu-
tants (pLGGL or pLGVL). However, in particles containing
RNA-binding domain mutant pDA1 there was little HDV
RNA (Fig. SA, lane 4). As a control for comparison, the HDV
RNA in transfected cells was investigated by Northern blotting
analysis (Fig. SB, arrow). After normalization of packaged
RNA to the level of cellular RNA, the efficiency of mutant
large HDAg (pDA1) in RNA packaging was found to be less
than 5% of the other three. Clearly, the large HDAg defective
in RNA binding was ineffective in assisting HDV RNA pack-
aging.
FIG. 6. Enhancement of HDV RNA packaging by the presence of
small HDAg. (A) Western blot to detect HDAg in virus-like particles.
Virions were recovered from culture media of Huh-7 cells cotrans-
fected with pCDm2G (10 jig) + pSjX (10 jtg) + pSVDAg-L (5 jig)
(lane 1) or the above three plasmids plus an increasing amount of
pSVDAg-S from 5 jig (lane 2), to 10 ,ug (lane 3), to 15 ,ug (lane 4).
Virions from Huh-7 cells cotransfected with pSVLD3 + pSIX (10 jig
each) were included as a positive control (lane 5). The positions ofthe
large (p27) and small (p24) HDAgs are at the right. Lane C, two
species of HDAg in the HDV virion used for markers. (B and C)
Northern blot of the HDV genome in the pellets from the experiment
shown in panel A (B) or in cotransfected cells (C). The organization of
these panels was identical to that described in the legend to panel A.
Arrows, monomer RNA. Lanes M and C, HDAg markers.
Enhancing role of small HDAg in HDV RNA packaging.
Both large and small HDAgs are present in HDV virions,
suggesting that both are important in RNA packaging. Com-
parison of HDV RNA levels in particles containing both
HDAgs with those of particles containing only large HDAg
revealed a significant difference. In the latter group of parti-
cles, the amount of packaged HDV RNA was much less
(compare middle gel of Fig. 4B with that of Fig. 4A). This
observation was consistent with an ineffective packaging of
HDV RNA in the absence of small HDAg.
To better understand the role of small HDAg in RNA
packaging, we did a titration experiment. The amounts of
HDV RNA-, HBsAg-, and large HDAg-expressing plasmids
were fixed, whereas that of small HDAg-expressing plasmid
was serially increased. However, the amount of small HDAg-
expressing plasmid was always kept below that of the large
HDAg-expressing plasmids. This precaution was taken to
prevent RNA replication, thereby ensuring that the HDV
RNA produced was dependent exclusively on the levels of
transfected plasmids. (As noted from previous studies, under
such a ratio of large to small HDAg little HDV RNA
replication could take place [5].)
Pellets from culture media of Huh-7 cells thus transfected
were prepared and used for immunoblotting to detect the
HDAgs. For the four transfection experiments, the amounts of
large HDAg-containing particles were equal (Fig. 6A, p27 in
lanes 1 to 4). The amounts of small HDAg in particles,
however, gradually increased in the last three samples (Fig 6A,
p24 in lanes 2 to 4) and paralleled the increase in the amount
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FIG. 7. Effect on HDV RNA packaging by wild-type and mutant small HDAg mutants. Huh-7 cells were cotransfected with pCDm2G, pSIX,
and pDA1 (expressing mutant large HDAg defective in RNA packaging) and no other plasmid (lane 1) orwith a plasmid expressingwild-type small
HDAg (lane 2), mutant small HDAg defective in the RNA-binding domain (pdAl, lane 3), mutant small HDAg defective in the oligomerization
domain (pSGGL, lane 4), mutant small HDAg partially defective in oligomerization (pSGVL, lane 5), or mutant small HDAg with a C-terminal
truncation (pddC, lane 6). Culture media and cells were collected at day 6 posttransfection for analysis of HDV. Virus-like particles were purified
from culture media, and RNAs were extracted for Northern blot detection of packaged HDV RNA (A). Results for immunoblot detection of
HDAgs in particles (B) and those for detection of expressed HDAgs in transfected cells (C) are shown. Results of riboprobe detection ofgenomic
HDV RNA (D) or antigenomic RNA (E) in transfected cells are shown. Lanes M, lambdaHindIII fragments as size markers; lanes C, HDV RNA
as markers.
of transfected small HDAg-expressing plasmid. Therefore, the
incorporation of small HDAg into particles increased as
anticipated.
We then determined the RNA content in these four groups
by hybridization with probes specific to HDV genomic RNA.
The amount ofpackaged HDV RNA was the least in particles
containing only large HDAg (Fig. 6B, lane 1). When small
HDAg was added to the particles, the amount of packaged
HDV RNA increased significantly (Fig. 6B, lanes 2 to 4).
Densitometer tracings of the HDV RNA hybridization signals
indicated a 6 to 10-fold increase in RNA packaging. To
compare the packaging efficiency more correctly, the relative
ratio ofthe RNAhybridization signal ofthe particles should be
further normalized to that of cellular HDV RNA (Fig. 6C,
lanes 1 to4). Afterthis conversion, the efficiencyofHDV RNA
packaging was found to increase to 4.2-fold when the ratio of
small to large HDAg was at 0.12, 4.6-fold with a ratio at 0.36,
and 4.4-fold at a ratio of 0.5. Thus, even a low level of
incorporation of small HDAg was effective in increasing the
efficiency of HDV RNA packaging, suggesting an important
role for small HDAg in RNA packaging.
HDV RNA packaging through direct binding with small
HDAg. In the above experiments, the particles containing both
HDAgs exhibited better HDV RNA packaging than those
containing only large HDAg. This raised the possibility that
small HDAg has an additional mechanism for RNApackaging.
To test this possibility, we used the mutantlarge HDAg, pDA1,
which had almost no RNA packaging activity, as shown in
previous cotransfection experiments (Fig. 5A, lane 4). The
advantage of using this mutant is that it allowed us to exclude
RNA packaging by large HDAg, thus simply addressing
whether small HDAg possessed independent RNA packaging
capacity.
Huh-7 cells were cotransfected with three plasmids express-
ing HDV RNA (pCDm2G), HBsAg (pSIX), and mutant large
HDAg defective in RNA packaging (pDA1) and with a
plasmid expressing either wild-type small HDAg or avariety of
mutant small HDAgs. Particles were purified from culture
media of the cotransfected cells and then subjected to immu-
noblotting and Northern blot analysis.
The particles containing mutant large HDAg defective in
RNA binding (pDA1) (Fig. 7B, p27 in lane 1) were unable to
package HDV RNA (Fig. 7A, lane 1). However, ifthe particles
also contained wild-type small HDAg (Fig. 7B, p24 in lane 2),
packaging of viral RNA could be recovered (Fig. 7A, lane 2).
The results clearly demonstrate that small HDAg has an RNA
packaging capacity independent of that of large HDAg. This
RNA packaging could take place first through direct HDV
RNA binding with small HDAg and then by a mutant large
HDAg interaction through its intact oligomerization domain
(3, 11). To further test this hypothesis, a mutant small HDAg
defective in RNA binding (pdAl), instead of the wild-type
small HDAg, was used in cotransfection. The mutant small
HDAg was packaged into particles (Fig. 7B, lane 3), but it was
unable to recover RNApackaging (Fig. 7A, lane3). These data
indicate that one mechanism for better HDV RNA packaging
in particles containing both large and small HDAgs could be
an additional, independent RNA packaging ability by small
HDAg.
However, an alternative explanation is that it is secondary to
an increase of cellular HDV RNA due to viral replication in
the presence of small HDAg. In cotransfection experiments
withwild-type small HDAg, although we kept the ratio oflarge
to small HDAg at a level unfavorable to HDV RNA replica-
tion (5), it was difficult to eliminate this possibility. As micro-
heterogeneity in mixtures of large to small HDAg-expressing
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plasmids could occur, some cells might experience a change in
the ratio of large to small HDAg which would allow some
RNAreplication. In fact, by the presence ofantigenomic RNA
in cotransfected cells we detected a low level of RNA replica-
tion in cells receiving pDA1 and pSVDAg-S (Fig. 7E, lane 2).
In order to exclude the effect of RNA replication resulting in
better RNA packaging, we further constructed a plasmid
expressing a C-terminally truncated smallHDAg (pddC) which
was unable to support HDV RNAreplication. In cells cotrans-
fectedwith this mutant, onlygenomic HDV RNAwas detected
(Fig. 7D and E, lanes 6). Characterization of the released
particles revealed that there was packaging ofthe C-terminally
truncated mutant small HDAg (pddC) (Fig. 7B, lane 6).
Interestingly, such particles still contained packaged HDV
RNA (Fig. 7A, lane 6). Results from this mutant study
suggested that the additional HDV RNA packaging ability by
the small HDAg did not depend on RNA replication.
Finally, we also studied the effects of oligomerization do-
main mutants of small HDAg on HDV RNA packaging.
Before the experiments, we anticipated little packaging of
HDV RNAby these mutants because they interactpoorlywith
the large HDAg and thus hinder packaging. However, in
studying the protein components of the released particles, we
did find packaging of a small amount of mutant small HDAg,
either pSGGL or pSGVL (Fig. 7B, lanes 4 and 5). It was
noteworthy that in cell lysates the amount of mutant small
HDAg pSGGL or pSGVL was more abundant than that of
large HDAg (Fig. 7C, lanes 4 and 5), just the opposite of the
levels in the particles. The results were consistent with a sharp
decline, but not a complete loss, of oligomerization activity of
such mutants. Nevertheless, such mutant small HDAgs, once
packaged into particles, retained their ability to package HDV
RNA, as shown in Fig. 7A, lanes 4 and 5.
DISCUSSION
Previous studies have shown that HBsAgs and large and
small HDAgs, coexpressed in the Huh-7 cells, can be assem-
bled into empty HDV-like particles that contain no viral RNA
(6, 16). Extending from such results, we added to the cotrans-
fection experiment another plasmid expressing a mutant HDV
RNA (2-base deletion in the HDAg ORF) to study HDV RNA
packaging. It was shown in this four-plasmid cotransfection
system that HDV RNA could be packaged (Fig. 3A, lane 3)
into virus-like particles.
With this in vitro packaging system, the four specific com-
ponents of the HDV virion could be provided separately, thus
allowing us to examine the role of each individual component
in RNA packaging. When small HDAg was left out of the
cotransfection, HDV RNA could still be packaged (Fig. 3A,
lane 4). This finding was further confirmed by isopycnic
centrifugation study of these particles, showing that fractions
containing the large HDAg and HDV RNA were coincident
(upper gel of Fig. 4B). Therefore, large HDAg alone was able
to bring HDV RNA into virus-like particles. Furthermore, we
demonstrated that the RNA-binding domainwas critical for its
role in RNA packaging. Once mutated, the mutant large
HDAg lost its RNA packaging ability, despite normal packag-
ing of mutant protein itself (Fig. 5A, lane 4). In contrast, the
oligomerization domain seemed unrelated to HDV RNA
packaging ability. Our results indicate a common RNA-bind-
ing domain involved in two important steps of the HDV life
cycle, namely, RNA replication and packaging.
Although the large HDAg alone could mediate packaging of
HDV RNA, the efficiency was low. From isopycnic centrifuga-
tion studies, fractions corresponding to large HDAg-contain-
ing particles carry much less HDV RNA than fractions corre-
sponding to particles containing both HDAgs (compare the
upper gels of Fig. 4A and B). Actually, we noted a separate,
minor peak fraction which appeared to contain large HDAg
only but little HDV RNA (fraction 17 in Fig. 4A and B, with a
density of 1.20 g/cm3). This suggested that a proportion of
large HDAg-containing particles were probably devoid of
HDV RNA. Ifthis interpretation is correct, it raises a question
about the significance and specificity of RNA packaging by
large HDAg. Probably otherviral or cellular factorswere more
important in determining the efficiency of HDV RNA packag-
ing.
In contrast, the density fractions from the particles contain-
ing both large and small HDAgs appeared always to be
associated with HDV RNA. Such observations suggested a
more active role of small HDAg in HDV RNA packaging. By
increasing the incorporation of small HDAg into particles, we
found a three to fourfold increase in HDV RNA packaging.
There could be multiple reasons for the more effective RNA
packaging by small HDAg. One possibility was that small
HDAg could support HDV RNA replication, thus increasing
the amount of cellular HDV RNA available for packaging.
However, this was not supported for two reasons. (i) The
comparison of packaged RNA was normalized to that of
cellular RNA, and (ii) the mutant small HDAg unable to
support HDV replication (pddC) was still able to enhance
HDV RNA packaging (data not shown).
Asecond possibilitywas that small HDAg possessed a better
RNA-binding activity than did large HDAg. However, in
previous Northwestern studies, the in vitro RNA-binding ac-
tivities between large and small HDAgs were shown to be
equivalent (12, 13) and therefore could not explain the differ-
ence seen in packaging. Another possibility was a difference in
accessibility of HDV RNA inside the cells. Actually, in trans-
fected or infected cells, most of the HDV RNA was found to
be associated with small HDAg not with large HDAg (17).
This compartmentalization effect could be a factor in deciding
the relative packaging efficiency of both HDAgs.
Finally, we provided experimental data supporting one
simple mechanism for this enhancement effect. Thiswas shown
to be a direct binding of HDV RNA to small HDAg, indepen-
dent from that of the large HDAg. In an experimental condi-
tion that prevented RNA packaging through large HDAg, we
found that small HDAg could still package HDV RNA. The
HDV RNA probably bound with small HDAg first, through
the RNA-binding domain of the protein. Then the ribonucle-
oprotein complex was introduced into the particle via a
protein-protein interaction with large HDAg. This possibility
was supported by the analysis ofanother RNA-binding domain
mutant of small HDAg. This mechanism probably occurred
naturally in HDV RNA packaging. A recent study of HDV
RNA in infected cells found little free HDV RNA, with most
existing as a ribonucleoprotein complex (17). Viral protein in
such a ribonucleoprotein complexwas found almost exclusively
in the small HDAg (17). If the precursor for virion RNA
(packaged RNA) was this ribonucleoprotein (inside the cells,
there was little HDV RNA existing in other form), packaging
probably proceeded through a protein interaction with the
large HDAg, as demonstrated in the above experiment (Fig.
7).
During the study, we found that the two oligomerization
domain mutants still retain some protein-protein interac-
tion capacity, although sharply decreased (especially mutant
pSGGL). They could be packaged by a weak interaction with
the large HDAg and they could even support a low level of
RNA replication. Probably such mutations did not abolish the
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oligomerization activity completely or there might also be a
minor protein-protein interaction domain other than the
coiled-coil structure. As has been noted previously, there is a
putative helix-loop-helix structure in the central RNA-binding
domain (4) which could be a candidate for a minor oligomer-
ization domain.
ACKNOWLEDGMENTS
We thank Michael M. C. Lai (University ofSouthern California) for
providing plasmids expressing mutant large and small HDAgs.
This work was supported by grants from the National Science
Council (NSC82-0419-B002-123MD) and Clinical Research Center,
National Taiwan University Hospital, Institute ofBiomedical Sciences,
Academia Sinica, Taiwan.
REFERENCES
1. Bonino, F., K. H. Heermann, M. Rizzetto, andW. H. Gerlich. 1986.
Hepatitis delta virus: protein composition of delta antigen and its
hepatitis B virus-derived envelope. J. Virol. 58:945-950.
2. Boshart, M., F. Webber, G. Jahn, K. Dorsch-Hasler, B. Fecken-
stein, and W. Schaffner. 1985. A very strong enhancer is located
upstream of an immediate early gene of human cytomegalovirus.
Cell 41:521-530.
3. Chang, F.-L., P.-J. Chen, S.-J. Tu, C.-J. Wang, and D.-S. Chen.
1991. The large form of hepatitis delta antigen is crucial for the
assembly of hepatitis delta virus. Proc. Natl. Acad. Sci. USA
88:8490-8494.
4. Chang, M.-F., C.-Y. Sun, C.-J. Chen, and S.-C. Chang. 1993.
Functional motifs of delta antigen essential for RNA binding and
replication of hepatitis delta virus. J. Virol. 67:2527-2532.
5. Chao, M., S.-Y. Hsieh, and J. Taylor. 1990. Role of two forms of
hepatitis delta virus antigen: evidence for a mechanism of self-
limiting genome replication. J. Virol. 64:5066-5069.
6. Chen, P.-J., F.-L Chang, C.-J. Wang, C.-J. Lin, S.-Y. Sung, and
D.-S. Chen. 1992. Functional study of hepatitis delta virus large
antigen in packaging and replication inhibition: role of the amino-
terminal leucine zipper. J. Virol. 66:2853-2859.
7. Chomcynski, P., and N. Sacchi. 1987. Single-step method of RNA
isolation by acid guanidium thiocyanate-phenol-chloroform ex-
traction. Anal. Biochem. 162:156-159.
8. Glenn, J. S., J. M. Taylor, and J. M. White. 1990. In vitro-
synthesized hepatitis delta virus RNA initiates genome replication
in cultured cells. J. Virol. 64:3104-3107.
9. Glenn, J. S., J. A. Watson, C. M. Havel, and J. M. White. 1992.
Identification of a prenylation site on delta virus large antigen.
Science 256:1331-1333.
10. Kuo, M. Y.-P., M. Chao, and J. Taylor. 1989. Initiation of
replication ofthe human hepatitis delta virus genome from cloned
DNA: role of delta antigen. J. Virol. 63:1945-1950.
11. Lazinski, D.W., andJ. Taylor. 1993. Relating structure to function
in hepatitis delta virus antigen. J. Virol. 67:2672-2680.
12. Lee, C.-Z., J.-H. Lin, M. Chao, K. McKnight, and M. M. C. Lai.
1993. RNA-binding activity of hepatitis delta antigen involves two
arginine-rich motifs and is required for hepatitis delta virus RNA
replication. J. Virol. 67:2221-2227.
13. Lin, J.-H., M.-F. Chang, S. C. Baker, S. Govindarajan, and
M. M. C. Lai. 1990. Characterization of hepatitis delta antigen:
specific binding to hepatitis delta virus RNA. J. Virol. 64:4051-
4058.
14. Nakabayashi, H., K. Taketa, K. Miyano, T. Yamane, and J. Sato.
1982. Growth of human hepatoma cell lines with differentiated
functions in chemically defined medium. Cancer Res. 42:3858-
3863.
15. Rizzetto, M., B. Hoyer, M. G. Canese, J. W. K. Shih, R. H. Purcell,
and J. L. Gerin. 1980. Delta agent: association of delta antigen
with hepatitis B surface antigen and RNA in serum of delta-
infected chimpanzees. Proc. Natl. Acad. Sci. USA 77:6124-6128.
16. Ryu, W.-S., M. Bayer, and J. Taylor. 1992. Assembly of hepatitis
delta virus particles. J. Virol. 66:2310-2315.
17. Ryu, W.-S., H. J. Netter, M. Bayer, and J. Taylor. 1993. Ribonu-
cleoprotein complexes of hepatitis delta virus. J. Virol. 67:3281-
3287.
18. Sureau, C., B. Guerra, and R. E. Lanford. 1993. Role of the large
hepatitis B virus envelope protein in infectivity of the hepatitis
delta virion. J. Virol. 67:366-372.
19. Sureau, C., A. M. Moriarty, G. B. Thornton, and R. E. Lanford.
1992. Production of infectious hepatitis delta virus in vitro and
neutralization with antibodies directed against hepatitis B virus
pre-S antigens. J. Virol. 66:1241-1245.
20. Tai, F.-P., P.-J. Chen, F.-L. Chang, and D.-S. Chen. 1993. Hepa-
titis delta virus cDNA monomer can be used in transfection
experiments to initiate viral RNA replication. Virology 197:137-
142.
21. Taylor, J. M. 1991. Hepatitis delta virus: cis and trans functions
required for replication. Cell 61:371-373.
22. Wang, C.-J., P.-J. Chen, J.-C. Wu, D. Patel, and D.-S. Chen. 1991.
Small-form hepatitis B surface antigen is sufficient to help in the
assembly of hepatitis delta virus-like particles. J. Virol. 65:6630-
6636.
23. Wang, K. S., Q.-L. Choo, A. J. Weiner, H.-J. Ou, R. C. Narajan,
R. M. Thayer, G. T. Mullenbach, K. J. Denniston, J. L. Gerin, and
M. Houghton. 1986. Structure, sequence and expression of the
hepatitis delta viral genome. Nature (London) 323:508-513.
24. Wu, J.-C., P.-J. Chen, Y.-P. Kuo, S.-D. Lee, D.-S. Chen, and L.-P.
Ting. 1991. Production of hepatitis D virus and suppression of
helper hepatitis B virus in a human hepatoma cell line. J. Virol.
65:1099-1104.
25. Xia, Y.-P., and M. M. C. Lai. 1992. Oligomerization of hepatitis
delta antigen is required for both the trans-activating and trans-
dominant inhibitory activities of the delta antigen. J. Virol.
66:6641-6648.
VOL. 68, 1994